Tata 1mg has crossed the 200-store mark, signalling a decisive push to build a nationwide omnichannel healthcare network that blends digital scale with neighbourhood access. Backed by Tata Digital, the platform is steadily expanding its physical presence even as its online pharmacy and diagnostics businesses continue to grow, reflecting a broader shift in how Indian consumers access healthcare services.
The company’s expansion comes alongside solid financial momentum. According to Tata Sons’ FY25 annual report, Tata 1mg posted consolidated revenue of about ₹2,392 crore in FY25, a year-on-year increase of roughly 22 percent from ₹1,968 crore in the previous year. Losses also narrowed to around ₹276 crore, pointing to improved cost controls and operational efficiencies in a category known for thin margins and high competition.
Tata 1mg’s offline footprint now spans more than 200 stores across a mix of metros and fast-growing Tier 1 and Tier 2 cities. These include large urban markets such as Delhi NCR, Bengaluru, Hyderabad and Kolkata, alongside cities like Jaipur, Lucknow, Dehradun, Ranchi and Jamshedpur. The rollout follows a phased approach, strengthening presence in high-demand metro clusters before extending deeper into emerging urban centres.
The physical stores function as neighbourhood health hubs, supporting Tata 1mg’s digital services with quicker medicine fulfilment, local diagnostics collection, assisted purchases and faster last-mile delivery. In select locations, the proximity of stores has enabled deliveries within 30 minutes, tightening the link between online demand and offline fulfilment.
Founded as a digital-first health platform, Tata 1mg has built a large user base around e-pharmacy, diagnostics, consultations and health content. Its growing retail network now adds a layer of trust and immediacy, particularly for elderly customers and chronic care needs.
Operating in a crowded market that includes PharmEasy, Netmeds and Apollo 24|7, Tata 1mg is leaning on brand credibility and integrated execution to differentiate itself. With revenue nearing ₹2,400 crore and a rapidly expanding store base, the company appears well placed to capitalise on India’s evolving preference for hybrid healthcare models that combine speed, access and reliability.










